WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 67, Issue 7, Pages 556-561
Publisher
BMJ
Online
2014-03-08
DOI
10.1136/jclinpath-2013-202114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prognostic effect of high diagnosticWT1gene expression in pediatric AML depends onWT1SNP rs16754 status: Report from the Children's Oncology Group
- (2013) Phoenix A. Ho et al. PEDIATRIC BLOOD & CANCER
- Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival
- (2012) Carlos Santamaría et al. ANNALS OF HEMATOLOGY
- The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor α-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL
- (2012) Hima Bansal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Use of 11C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma
- (2012) Yasuyoshi Chiba et al. JOURNAL OF NEUROSURGERY
- Identification of a Wilms’ tumor 1-derived immunogenic CD4+ T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes
- (2012) S Anguille et al. LEUKEMIA
- Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes
- (2010) David Capper et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- WT1 Is Not a Reliable Marker to Distinguish Reactive from Neoplastic Astrocyte Populations in the Central Nervous System
- (2010) T. David Bourne et al. BRAIN PATHOLOGY
- Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients
- (2010) Yasuyoshi Chiba et al. Brain Tumor Pathology
- Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes
- (2009) A. Li et al. CANCER RESEARCH
- High-Grade Astrocytomas Show Increased Nestin and Wilms’s Tumor Gene (WT1) Protein Expression
- (2009) Elisabeth J. Rushing et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Nogo-A Expression in Glial CNS Tumors
- (2008) Tanja Kuhlmann et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- WT1 Expression Distinguishes Astrocytic Tumor Cells from Normal and Reactive Astrocytes
- (2008) Jens Schittenhelm et al. BRAIN PATHOLOGY
- Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
- (2008) Shuichi Izumoto et al. JOURNAL OF NEUROSURGERY
- Diagnostic value of WT1 in neuroepithelial tumours
- (2008) J. Schittenhelm et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started